Alkermes plc. Area of Real Estate Property
Alkermes plc. (ALKS) had Area of Real Estate Property of 180.00 thousand sqft as of 2020-10-07, per its 10-K filed 2023-02-16.
Discontinued › Notes
us-gaap:AreaOfRealEstateProperty · last filed 2023-02-16
- 2020-10-07: Area of Real Estate Property 180.00K sqft.
- 2020-01-20: Area of Real Estate Property 231.00K sqft.
- 2018-03-31: Area of Real Estate Property 231.00K sqft; Area of Real Estate Property as first filed 220.00K sqft.
- 2017-03-31: Area of Real Estate Property 65.00K sqft.
| Period end | Area of Real Estate Property | Area of Real Estate Property as first filed |
|---|---|---|
| 2020-10-07 | 180.00K sqft 10-K · filed 2023-02-16 | |
| 2020-01-20 | 231.00K sqft 10-K · filed 2023-02-16 | |
| 2018-03-31 | 231.00K sqft 10-K · filed 2022-02-16 | 220.00K sqft 10-Q · filed 2018-04-26 |
| 2017-03-31 | 65.00K sqft 10-Q · filed 2017-10-26 | |
| 2017-03-01 | 43.29K sqft 10-Q · filed 2017-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |